Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2002

View Archived Issues

Metvix PDT receives marketing authorization in Germany

Cidecin NDA to be filed by end of 2002

Interneuron initiates phase I trial of dersalazine

Patient enrollment target met in phase II/III trial of Onco TCS in relapsed aggressive NHL

Approval of LeukoScan recommended in Australia

Discovery Laboratories and Esteve sign expanded agreement for Surfaxin

Rebif approved, launched in U.S. for relapsing forms of multiple sclerosis

New combination treatment for advanced hepatocellular carcinoma is safe, beneficial

Addiction Therapies approaches behavioral disorders using active cognitive pharmacotherapy

Treatment-resistant schizophrenics benefit from addition of Ginkgo biloba extract to therapy

Botulinum toxin type A safe and potentially effective adjunct for poststroke upper limb spasticity

New drug candidate for Alzheimer's disease emerges from Samaritan-Georgetown alliance

Effects of NIP-141 on K+ channels evaluated in human myocytes

Low-dose IL-2 may prevent progression to liver cirrhosis in HIV/HCV-coinfected patients

NeuroSearch summarizes last year's development highlights

Lexicon Genetics highlights 2001 achievements

Novel approach to enhancing antitumor immunity with dendritic cell-based vaccines

Phase IIa trial of PCK-3145 in prostate cancer cleared by MCA

Oncolytics Biotech files IND for clinical trial of Reolysin in recurrent malignant glioma

Zentaris patents compounds useful for treating acromegaly

Metalloprotease inhibitors and their uses reported by Roche

Merck & Co. describes novel derivatives with antithrombotic activity

University research leads to novel PLA2 inhibitors for the treatment of inflammatory diseases

Novel glucokinase activators in the pipeline at Roche

Merck & Co. scientists prepare new series of PPARgamma agonists

Analgesic compounds reported by Gruenenthal in patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...